MAPK8 and Insulin resistance: The cellular repressor of E1A‐stimulated genes (CREG) is another novel cellular target that affects ASK1 activity, which directly interacts with ASK1 and inhibits its phosphorylation, thereby blocking the downstream JNK1 signalling pathway and dramatically reducing obesity‐insulin resistance.15